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Abstract
Using data provided by the Collaborative Study on the Genetics of Alcoholism we studied the
genetics of a quantitative trait: the maximum number of drinks consumed in a 24-hour period. A
two-stage method was used. First, linkage analysis was performed, followed by association analysis
in regions where linkage was detected. Additionally, the extent of linkage disequilibrium among
single-nucleotide polymorphisms (SNP) associated with the phenotype was assessed. Linkage to
chromosomes 2 and 7 was detected, and follow-up association analysis found multiple traitassociated SNPs in the chromosome 7 linkage region. Chromosome 4, which has been implicated
in previous studies of the maximum drinks phenotype, did not pass our threshold for linkage
evidence in stage 1, but secondary analyses of this chromosome indicated modest evidence for both
linkage and association. The evidence suggests that chromosome 7 may harbor an additional locus
influencing the maximum drinks consumption phenotype.

Background
The data provided by the Collaborative Study on the
Genetics of Alcoholism (COGA) for Genetic Analysis
Workshop 14 (GAW14) includes the "maximum number
of drinks consumed in a 24-hour period." This phenotype
is closely related to alcoholism diagnosis, and a previous
genome screen of this phenotype in COGA resulted in evidence for linkage to chromosome 4 in the vicinity of the
alcohol dehydrogenase (ADH) gene cluster [1]. The
GAW14 dataset provides nearly 16,000 genotyped singlenucleotide polymorphisms (SNP) that were not available
in the original COGA data. For this report we have analyzed these additional genotypic data to see whether the
original linkage findings can be confirmed or extended.
Linkage signals were followed up with association analysis to make use of the density of the SNP data to refine

linkage signals and potentially localize genetic variants
that may influence alcohol consumption.

Methods
In defining the quantitative trait, we set the phenotype of
individuals who report a maximum drinks value of zero to
be unknown, since these unexposed individuals have
undetermined response to alcohol. We reduced skewness
by taking the logarithm of the maximum number of
drinks. A linear regression was used to correct for sex, and
the final trait value was defined as the residual from the
regression.
Our primary analysis consisted of two stages, applied to
the cleaned SNP data. In the first stage we tested for
genetic linkage using the SNP marker data provided by
Illumina. Nonparametric two-point quantitative trait
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Table 1: Two-point linkage (TPL-stage 1) and trait association (QPDT-stage 2) results for chromosome 2

Marker
rs1025053
tsc0875114
rs1525351
a-,

Source

MAF

Mbp

cM

Method

LOD

χ2

p-value

Illum
Affy
Illum

0.47
0.21
0.44

8.238
8.345
216.466

16.1
21.7
212.9

TPL
QPDT
TPL

1.97
-a
2.68

9.05
-

0.003
-

not applicable.

linkage analysis was performed using the "--qtl" option of
the program MERLIN [1]. The method compares allele
sharing among individuals with similar phenotypes; individuals at extreme ends of the distribution are given
greater weight. We chose two-point rather than
multipoint analysis because strong linkage disequilibrium
(LD) among the densely spaced SNP markers could lead
to inflated evidence for linkage if multipoint methods are
used without accounting for marker-marker LD. Markers
exhibiting linkage with a LOD score greater than 1.8 were
used to define regions for further study. In the second
stage a 20-cM interval centered at the marker was used to
test for trait association. SNPs in this interval from the
combined Illumina and Affymetrix sets were analyzed for
trait association using the quantitative pedigree disequilibrium test (QPDT) [2] as implemented in the program
UNPHASED [3]. Our choice to use the Illumina SNP set
(4,710 markers) for the first stage and the Affymetrix SNP
set (11,120 markers) together with the Illumina set for the
follow-up association analysis allowed us to carry out the
initial genome screen and then proceed with fine-mapping in regions of linkage using the more densely spaced
SNPs provided by Affymetrix.
To supplement our primary two-stage analysis, we carried
out some related additional analyses. These are described
below.
For comparison with the stage 1 SNP linkage screen, linkage analysis of the autosomal microsatellite data was performed using the same two-point nonparametric analysis
as above. We also repeated this microsatellite analysis
using a 2-cM multipoint grid because LD among these
markers was not a significant concern.
For chromosome 4, prior linkage evidence for the maximum drinks phenotype has been reported [1], making
this a chromosome of special interest. Using the Illumina
markers for chromosome 4, we then tested for linkage in
the first stage using a regression of the estimated IBD status against the squared sum and squared difference of the
trait values, as implemented by the program MERLINREGRESS [4]. As this analysis method is computationally
intensive, we applied it only to chromosome 4, allowing
a more comprehensive study of this chromosome of interest.

LD between markers should be considered when using
SNP data to search for disease or trait association. Thus,
SNPs exhibiting trait association in our primary analysis
that were also in close proximity to one another were
tested to see if they were in LD with each other. Pair-wise
LD coefficients were computed using the program
LDMAX, which is part of the GOLD computer package [5];
results are reported using the normalized coefficient D' =
D/|D|max, where D = p11 - p1 p2, p11 is the frequency for the
haplotype containing allele 1 at both markers, pi is the frequency of allele 1 at the ith marker of the pair, and |D|max
is the maximum possible (absolute) value of D given the
marker allele frequencies.

Results
Out of a sample of 1,614 individuals, the maximum
number of drinks was recorded for 1,388 (86%) individuals. The mean, median, and mode were 17.8, 12, and 24,
respectively, with a standard deviation of 17.3. Due to
computer memory constraints, 9 out of 143 families
(6%), consisting of 243/1,614 (15%) individuals, were
automatically dropped by MERLIN from the linkage analysis in stage 1, and this reduction in sample is a limitation
of our analyses. The average maximum drinks value in the
dropped families was slightly lower than the overall average (by 0.16 of a standard deviation); this difference does
not appear to have a systematic cause and is not expected
to affect the interpretability of the results.
We used 4,710 markers from the Illumina SNP set. The
mean spacing between markers was 0.77 cM on the
genetic map and 621 kb on the physical map, and the
mean minor allele frequency (MAF) was 0.39. We used
11,120 markers from the Affymetrix SNP set. The mean
spacing was 0.32 cM (258 kb on the physical map), and
the mean MAF was 0.27.
In our primary analysis, only chromosomes 2 and 7 were
found to have LOD scores over 1.8 at stage 1. Tables 1 and
2 show the results of the combined two-point linkage and
trait association analysis (QPDT) for these two chromosomes. For the stage 2 association analyses, the tables
report only those SNPs significant at the 0.01 level. We
note that while multiple SNPs throughout the linked
regions were significant at the 0.05 level, only one SNP on
chromosome 2 and multiple SNPs on chromosome 7
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Table 2: Two-point linkage (stage 1) and trait association (QPDT-stage 2) results for chromosome 7

Marker
tsc0229102
rs727708
rs719530
rs846427
rs1860487
tsc0064426
tsc1086900
tsc0058943
rs322812
a-,

Source

MAF

Mbp

cM

Method

LOD

χ2

p-value

Affy
Illum
Illum
Illum
Illum
Affy
Affy
Affy
Illum

0.46
0.49
0.42
0.38
0.47
0.37
0.37
0.42
0.44

89.250
102.891
109.451
119.048
123.270
124.757
124.758
124.791
127.299

101.9
114.2
121.8
127.3
129.3
128.6
128.6
128.6
131.3

QPDT
TPL
TPL
TPL
TPL
QPDT
QPDT
QPDT
TPL

-a
2.28
2.14
2.17
1.91
2.77

7.29
7.53
8.23
7.91
-

0.007
0.006
0.004
0.005
-

not applicable.

gave association results significant at the 0.01 level. Table
3 lists the results for the additional two-point regression
analysis performed on chromosome 4 by MERLINREGRESS and the QPDT results computed by
UNPHASED for SNPs in the linkage regions detected by
the regression. The maximal LOD of 2.14 occurred at 97.4
Mb (100.4 cM).

chromosome 15 at D15S230 (LOD = 1.43, position =
135.6 cM) and D15S642 (LOD = 1.12, position = 152.1
cM). For the multipoint analysis, the only LOD score over
1.0 was 1.49, which occurred on chromosome 15 at 142
cM. Thus, in a direct comparison of the two-point screens
using SNPs versus microsatellites, it is curious that higher
LOD scores were detected with the SNPs than with the
microsatellites, even though the SNPs are individually less
informative. It may be the density of the SNP map that
was beneficial and allowed the detection of linkage evidence that was missed by the microsatellite screen. To
examine this hypothesis, we compared the locations of
the trait-linked SNP markers on chromosomes 2 and 7 to
the locations of the microsatellite markers using integrated map information from the National Center for Biotechnology Information (NCBI) [6], specifically, the
NCBI build 35.1 reference assembly. This assembly places
the peak SNP on chromosome 7, rs322812, at 127.338
Mb. This falls near the midpoint of the flanking microsatellites, which are located at 122.205 Mb and 131.736 Mb
of the same build, indicating a modest gap, which is also
borne out by the genetic positions of these microsatellites
at 146.7 cM and 156.2 cM on the GAW14 map. However,
for some of the other trait-linked SNPs, there do appear to

We computed values of D' for the significantly associated
SNPs on chromosomes 2 and 7 (Tables 1 and 2). Thus, we
focused on chromosome 7 because multiple significant
SNPs were detected there. An LD block extended from
124.757 Mb to 124.791 Mb, covering the three most significantly associated SNPs; in fact, this block satisfied |D'|
≥ 0.9 for all marker pairs. Thus, the evidence for association in this region does not come from three independent
SNPs but rather indicates a single LD block associated
with the phenotype.
Our analyses of the microsatellite data found no evidence
for linkage satisfying our LOD threshold of 1.8 in either
the two-point or the multipoint screens. For the two-point
screen, the only LOD scores over 1.0 occurred on chromosome 7 at D7S821 (LOD = 1.13, position = 116.6 cM) and

Table 3: Two-point regression (stage 1) and trait association (QPDT-stage 2) results for chromosome 4

Marker
tsc0592063
rs936232
rs1031739
rs2046015
rs0965823
rs1378876
rs960345
rs0724156
rs1365372
a-,

Source

MAF

Mbp

cM

Method

LOD

χ2

p-value

Affy
Illum
Illum
Illum
Affy
Illum
Illum
Affy
Illum

0.45
0.42
0.40
0.43
0.49
0.37
0.46
0.24
0.12

13.984
25.564
87.688
94.144
96.436
97.354
105.689
131.384
139.914

27.3
37.1
93.1
98.1
102.3
100.4
105.6
128.1
129.8

QPDT
REG
QPDT
QPDT
QPDT
REG
QPDT
QPDT
REG

-a
1.94
2.14
1.91

11.38
6.99
7.47
4.35
8.50
8.62
-

0.001
0.008
0.006
0.037
0.004
0.003
-

not applicable.
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be microsatellites positioned relatively close by. Other
possible explanations for the higher LOD scores in the
SNPs could be higher genotyping success rates in the SNPs
or greater genotyping error in the microsatellites. The discrepancy could also be due to chance, for example if less
informative SNPs resulted in some families being uninformative for linkage who might otherwise have contributed evidence against linkage.
Note also that in the microsatellite screens, the two-point
analysis in many instances found higher LOD scores than
the multipoint analysis. For example, the two-point analysis found weak evidence on chromosome 7 with a LOD
score over 1 at 116.6 cM (in the vicinity of the SNP linkage
signals), while multipoint LOD scores did not reach 1 on
chromosome 7 (the maximum LOD was 0.89 at 140 cM).

Conclusion
Our two-stage genome-wide analysis implicates chromosomes 2 and 7 as potentially harboring loci influencing
the maximum drinks consumption phenotype. Follow-up
association analysis supports chromosome 7 more
strongly than chromosome 2, and suggests that further
fine-mapping efforts on chromosome 7 may be constructive. Interestingly, this region of chromosome 7q contains
several TAS2R bitter taste receptor genes [7], and haplotype status at one of these, TAS2R38, has been shown to
be a significant predictor of alcohol intake [8]. The muscarinic receptor CHRM2 gene associated with alcohol
dependence and major depressive syndrome in COGA [9]
is also in this region.

LD between markers is a concern when using multipoint
linkage analysis, and our results show there is strong LD
among SNPs on chromosome 7 which were found to be
associated with maximum drinks. As an additional analysis we studied global LD structure using an algorithm we
have previously described [10] to produce a non-overlapping set of blocks across all the chromosomes in the Illumina and Affymetrix SNP sets and found a significant
amount of LD and variable block coverage on the different chromosomes, as expected. We are developing techniques for selecting "tag" SNPs from LD blocks which
should be useful in this context by allowing maps to be
thinned for multipoint linkage analysis, or by targeting
"tag" SNPs for priority genotyping.
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